Fluoroquinolone exposure prior to tuberculosis diagnosis is associated with an increased risk of death
The International Journal of Tuberculosis and Lung Disease, 08/10/2012
van der Heijden YF et al. – Among this patient population, Fluoroquinolone (FQ) exposure before tuberculosis (TB) diagnosis was associated with an increased risk of death. These findings underscore the need for cautious use of FQs in persons with possible TB.